The aim was to evaluate the effectiveness of a multipronged intervention on diabetic dilated fundus examination (DFE) adherence. In a prospective trial, 521 patients with diabetes who were due for follow-up DFEs were randomized to usual care or the intervention group. Usual care received a form letter reminder to schedule and an automated reminder phone call prior to their appointment. Intervention participants received an educational brochure about diabetic eye disease and a personalized letter reminder to schedule. A research assistant called intervention participants to help schedule the appointment, and they received a reminder letter and an automated phone call prior to the scheduled visit. Patients in the intervention group were significantly more likely to schedule (63% vs 40%; P < .0001) and complete their appointment (48% vs 30%; P < .0001) compared with usual care. A multipronged intervention, including an educational mailing and telephone assistance with scheduling an appointment, significantly improved diabetic DFE adherence.
KempenJHO’ColmainBJLeskeMC. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122:552-563.
2.
VitaleSCotchMFSperdutoRD. Prevalence of visual impairment in the United States. JAMA. 2006;295:2158-2163.
3.
KleinBE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007;14:179-183.
4.
FrankRN. Diabetic retinopathy. N Engl J Med. 2004;350:48-58.
5.
Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology. 1981;88:583-600.
6.
Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study Research Group. Arch Ophthalmol. 1985;103:1796-1806.
7.
FerrisFLIII. How effective are treatments for diabetic retinopathy?JAMA. 1993;269:1290-1291.
8.
VijanSHoferTPHaywardRA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA. 2000;283:889-896.
9.
JavittJCAielloLP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124(1, pt 2):164-169.
10.
JavittJCAielloLPChiangYFerrisFLIIICannerJKGreenfieldS. Preventive eye care in people with diabetes is cost-saving to the federal government: implications for health-care reform. Diabetes Care. 1994;17:909-917.
11.
SloanFAPiconeGBrownDSLeePP. Longitudinal analysis of the relationship between regular eye examinations and changes in visual and functional status. J Am Geriatr Soc. 2005;53:1867-1874.
12.
JavittJC. Universal coverage and preventable blindness. Arch Ophthalmol. 1994;112:453.
American Diabetes Association. Diabetic retinopathy. Diabetes Care. 2000;23(suppl 1):S73-S76.
15.
ZhangXSaaddineJBLeePP. Eye care in the United States: do we deliver to high-risk people who can benefit most from it?Arch Ophthalmol. 2007;125:411-418.
16.
BrooksRJLegorretaAPSilverALFabiusRJKrakovitzJ. Implementing guidelines for eye care of diabetic patients: results from an HMO intervention study. Am J Manag Care. 1996;2:365-369.
17.
HalbertRJLeungKMNicholJMLegorretaAP. Effect of multiple patient reminders in improving diabetic retinopathy screening: a randomized trial. Diabetes Care. 1999;22:752-755.
18.
LegorretaAPHasanMMPetersALPelletierKRLeungKM. An intervention for enhancing compliance with screening recommendations for diabetic retinopathy: a bicoastal experience. Diabetes Care. 1997;20:520-523.
19.
RoterDLHallJAMeriscaRNordstromBCretinDSvarstadB. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36:1138-1161.
20.
GierischJMDeFrankJTBowlingJM. Finding the minimal intervention needed for sustained mammography adherence. Am J Prev Med. 2010;39:334-344.
21.
VogtTMGlassAGlasgowRELa ChancePALichtensteinE. The safety net: a cost-effective approach to improving breast and cervical cancer screening. J Womens Health (Larchmt). 2003;12:789-798.
22.
AndersonRMMuschDCNwankwoRB. Personalized follow-up increases return rate at urban eye disease screening clinics for African Americans with diabetes: results of a randomized trial. Ethn Dis. 2003;13:40-46.
23.
OrrPBarronYScheinODRubinGSWestSK. Eye care utilization by older Americans: the SEE Project. Salisbury Eye Evaluation. Ophthalmology. 1999;106:904-909.
24.
WangFJavittJC. Eye care for elderly Americans with diabetes mellitus: failure to meet current guidelines. Ophthalmology. 1996;103:1744-1750.
25.
EllishNJRoyak-SchalerRPassmoreSRHigginbothamEJ. Knowledge, attitudes, and beliefs about dilated eye examinations among African-Americans. Invest Ophthalmol Vis Sci. 2007;48:1989-1994.
26.
HartnettMEKeyIJLoyacanoNMHorswellRLDesalvoKB. Perceived barriers to diabetic eye care: qualitative study of patients and physicians. Arch Ophthalmol. 2005;123:387-391.
27.
WalkerEABaschCEHowardCJZybertPAKromholzWNShamoonH. Incentives and barriers to retinopathy screening among African-Americans with diabetes. J Diabetes Complications. 1997;11:298-306.
